ZEB1's Role in Reducing Adenoviral Infection in Cancer Cells
Author Information
Author(s): Lacher Markus D, Shiina Marisa, Chang Peter, Keller Debora, Tiirikainen Maarit I, Korn W Michael
Primary Institution: University of California, San Francisco
Hypothesis
ZEB1 represses the expression of the Coxsackie virus and Adenovirus Receptor (CAR) in cancer cells, affecting adenoviral infectability.
Conclusion
Inhibiting ZEB1 may enhance adenovirus uptake in cancer cells that have undergone epithelial-to-mesenchymal transition (EMT).
Supporting Evidence
- ZEB1 represses CAR expression in both pancreatic and breast cancer cells.
- Silencing ZEB1 in MDA-MB-231 cells induced a partial mesenchymal-to-epithelial transition.
- Knockdown of ZEB1 in PANC-1 cells increased adenovirus uptake.
Takeaway
ZEB1 is a protein that helps cancer cells avoid being infected by certain viruses. If we can turn off ZEB1, the cancer cells might let the viruses in better, which could help treat the cancer.
Methodology
The study involved silencing ZEB1 in cancer cell lines and measuring the effects on CAR expression and adenoviral uptake through various assays.
Potential Biases
Potential bias in the interpretation of ZEB1's role due to the focus on specific cell lines.
Limitations
The study primarily focused on two cancer cell lines, which may not represent all cancer types.
Participant Demographics
The study used human pancreatic (PANC-1) and breast (MDA-MB-231) cancer cell lines.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website